Zhongqi Phyllis Wu

Zhongqi Phyllis Wu has a diverse and extensive work experience in the pharmaceutical and clinical research field. Zhongqi Phyllis is currently serving as the Clinical Operation Director at EpimAb Biotherapeutics, Inc. starting from January 2021.

Prior to that, Zhongqi worked at AstraZeneca for a significant period. Zhongqi Phyllis held multiple roles including HGR super user from April 2020 to December 2020, Global Study Leader from May 2019 to December 2020, Clinical Development Associate Manager from April 2014 to June 2019, Project Management Lead from June 2017 to March 2018, and Hub Communication Team Leader from January 2015 to March 2017.

Before joining AstraZeneca, Zhongqi worked at UCLA as a Clinical Regulatory Coordinator from September 2010 to March 2014. Zhongqi Phyllis also served as a Graduate Student Researcher at UCLA from September 2002 to September 2009.

Overall, Zhongqi Phyllis Wu has amassed valuable experience and expertise in clinical operations, study leadership, project management, and regulatory coordination throughout their career in the pharmaceutical industry.

Zhongqi Phyllis Wu pursued their education with a strong focus on science. Zhongqi Phyllis started their academic journey at Virginia Tech, where from 1998 to 2002, they earned a Bachelor of Science degree (Cum Laude) in Biochemistry. Zhongqi then proceeded to further enhance their expertise by attending UCLA, where they dedicated herself to the field of Neuroscience. Zhongqi Phyllis successfully completed their Ph.D. in Neuroscience from UCLA during the period of 2002 to 2009.